
Company Info
Year Established2016
Contacts
Paul Ashton, Ph.D.Co-Founder, Chair & CEO
Company Description
Inflammasome Therapeutics is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.
